156 related articles for article (PubMed ID: 25784576)
1. Estimating demand and unmet need for allogeneic hematopoietic cell transplantation in the United States using geographic information systems.
Besse KL; Preussler JM; Murphy EA; Denzen EM; Lill MC; Chell JW; Senneka MK; Majhail NS; Williams EP
J Oncol Pract; 2015 Mar; 11(2):e120-30. PubMed ID: 25784576
[TBL] [Abstract][Full Text] [Related]
2. Venous Thromboembolism in Pediatric Hematopoietic Cell Transplant: A Multicenter Cohort Study.
Rangarajan HG; Stanek JR; Abu-Arja R; Bajwa RPS; Auletta JJ; Lee DA; O'Brien SH; Kumar R
Biol Blood Marrow Transplant; 2018 Feb; 24(2):337-342. PubMed ID: 29128552
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).
Gabriel M; Shaw BE; Brazauskas R; Chen M; Margolis DA; Sengelov H; Dahlberg A; Ahmed IA; Delgado D; Lazarus HM; Gibson B; Myers KC; Kamble RT; Abdel-Mageed A; Li CK; Flowers MED; Battiwalla M; Savani BN; Majhail N; Shaw PJ
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1320-1326. PubMed ID: 28411175
[TBL] [Abstract][Full Text] [Related]
4. Access to hematopoietic stem cell transplantation: effect of race and sex.
Joshua TV; Rizzo JD; Zhang MJ; Hari PN; Kurian S; Pasquini M; Majhail NS; Lee SJ; Horowitz MM
Cancer; 2010 Jul; 116(14):3469-76. PubMed ID: 20564154
[TBL] [Abstract][Full Text] [Related]
5. Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.
Passweg JR; Baldomero H; Ansari M; Baerlocher GM; Bargetzi M; Chalandon Y; Duchosal MA; Gerull S; Güngör T; Halter JP; Heim D; Hess U; Leibundgut K; Masouridi-Levrat S; Müller A; Nair G; Pabst T; Renner C; Schmidt A; Stussi G; Nicoloso de Faveri G; Schanz U; For The Swiss Blood Stem Cell Transplantation Group Sbst
Swiss Med Wkly; 2018; 148():w14589. PubMed ID: 29493715
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hematopoietic cell transplant survivors in the United States.
Majhail NS; Tao L; Bredeson C; Davies S; Dehn J; Gajewski JL; Hahn T; Jakubowski A; Joffe S; Lazarus HM; Parsons SK; Robien K; Lee SJ; Kuntz KM
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1498-501. PubMed ID: 23906634
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with improved outcomes after second allogeneic hematopoietic cell transplantation for relapsed pediatric leukemia.
Menon NN; Jenkins LM; Cui H; Jenkins C; Anwer F; Yeager AM; Katsanis E
Ann Hematol; 2016 Mar; 95(4):637-44. PubMed ID: 26787415
[TBL] [Abstract][Full Text] [Related]
8. Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant.
Barata A; Wood WA; Choi SW; Jim HS
Curr Hematol Malig Rep; 2016 Aug; 11(4):280-7. PubMed ID: 27113094
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic transplant physician and center capacity in the United States.
Majhail NS; Murphy EA; Omondi NA; Robinett P; Gajewski JL; LeMaistre CF; Confer D; Rizzo JD
Biol Blood Marrow Transplant; 2011 Jul; 17(7):956-61. PubMed ID: 21540121
[TBL] [Abstract][Full Text] [Related]
10. Geographic access to hematopoietic cell transplantation services in the United States.
Delamater PL; Uberti JP
Bone Marrow Transplant; 2016 Feb; 51(2):241-8. PubMed ID: 26457909
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.
Shaw BE; Brazauskas R; Millard HR; Fonstad R; Flynn KE; Abernethy A; Vogel J; Petroske C; Mattila D; Drexler R; Lee SJ; Horowitz MM; Rizzo JD
Cancer; 2017 Dec; 123(23):4687-4700. PubMed ID: 28817182
[TBL] [Abstract][Full Text] [Related]
13. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
14. High-risk centers and the benefits for lower-risk transplants.
Marmor S; Begun JW; Abraham J; Virnig BA
Am J Manag Care; 2015 Sep; 21(9):e509-18. PubMed ID: 26618438
[TBL] [Abstract][Full Text] [Related]
15. Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers.
Foster J; Moore H; Preussler JM; Burns LJ; Umar JH; Glotzbecker B; Johnson S; MacDougall H; Mau LW; Murphy EA; Ustun C; Ferguson SS; Denzen E
J Cancer Educ; 2020 Aug; 35(4):651-660. PubMed ID: 30877651
[TBL] [Abstract][Full Text] [Related]
16. A review of hematopoietic cell transplantation in China: data and trends during 2008-2016.
Xu LP; Wu DP; Han MZ; Huang H; Liu QF; Liu DH; Sun ZM; Xia LH; Chen J; Wang HX; Wang C; Li CF; Lai YR; Wang JM; Zhou DB; Chen H; Song YP; Liu T; Liu KY; Huang XJ
Bone Marrow Transplant; 2017 Nov; 52(11):1512-1518. PubMed ID: 28436973
[TBL] [Abstract][Full Text] [Related]
17. Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies.
Bonafede M; Richhariya A; Cai Q; Josephson NC; McMorrow D; Garfin PM; Perales MA
J Med Econ; 2017 Dec; 20(12):1244-1251. PubMed ID: 28782449
[TBL] [Abstract][Full Text] [Related]
18. The National Marrow Donor Program: improving access to hematopoietic cell transplantation.
Walker T; Milford E; Chell J; Maiers M; Confer D
Clin Transpl; 2011; ():55-62. PubMed ID: 22755401
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients.
Garnica M; da Cunha MO; Portugal R; Maiolino A; Colombo AL; Nucci M
Clin Infect Dis; 2015 Mar; 60(6):875-80. PubMed ID: 25425628
[TBL] [Abstract][Full Text] [Related]
20. HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.
Verneris MR; Lee SJ; Ahn KW; Wang HL; Battiwalla M; Inamoto Y; Fernandez-Vina MA; Gajewski J; Pidala J; Munker R; Aljurf M; Saber W; Spellman S; Koreth J
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1783-9. PubMed ID: 26055300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
